Advanced Techniques for Statistical Analyses in INPADOC on STN E-Seminar, Jan Baur
Agenda • INPADOCDB / INPAFAMDB database structure • Commands and tools for statistical analysis • Analysis examples – – – – – – –
Company filing activity by year Company filing activity by year and country Patent portfolio Measuring the average patent lifespan Opposing companies Competitor citations Filing activity in a technical area by company
• Useful tools for compiling Company name queries
2
Agenda • INPADOCDB / INPAFAMDB database structure • Commands and tools for statistical analysis • Analysis examples – – – – – – –
Company filing activity by year Company filing activity by year and country Patent portfolio Measuring the average patent lifespan Opposing companies Competitor citations Filing activity in a technical area by company
• Useful tools for compiling Company name queries
3
INPADOCDB facts and figures • 76 million documents / 42 million patent families • Bibliographic and patent family information for more than 95 patent authorities from the mid1800’s • Abstracts for more than 50 patent authorities • Cited references from 26 patent authorities • Classification codes IPC, CPC, NCL, FTRM, FCL • Legal status for 59 patent authorities from 1978 • Calculated expiration dates for 30 patent authorities 4
FIZ Karlsruhe editorial corrections provide more accurate INPADOC patent families • Accurate patent families rely on accurate publication, application and priority numbers • Quality control and correction process – all numbers which do not meet the standardized number formats are filtered out and corrected manually – serial corrections are processed automatically – app. 2.200 standards are maintained for quality checks
• Errors reported by users are corrected intellectually • Error corrections are typically online one week after the error has been detected 5
INPADOCDB vs. INPAFAMDB
legal status
publication 2 PI EP1130059 B1 legal status
publication 1 PI US20010031805 A1 publication 2 PI US6528560 B2 legal status
INPADOC record 3
publication 2 PI DE10009756 B4
publication 1 PI EP1130059 A1
INPADOC record 2
publication 1 PI DE10009756 A1
INPADOC record 1
• An INPADOCDB record includes all patent publications issued by the same authority
publication 1 PI DE10009756 A1
publication 1 PI EP1130059 A1
publication 1 PI US20010031805 A1
publication 2 PI DE10009756 B4
publication 2 PI EP1130059 B1
publication 2 PI US6528560 B2
legal status
legal status
legal status
INPAFAM record 1
• All patent publications of one patent family (invention) form one record in INPAFAMDB
6
INPADOCDB/INPAFAMDB: When to use which file INPADOCDB (application file)
INPAFAMDB (family file)
Use: Analyse the number of filings; Patent assignee and legal status
Use: Analyse number of inventions
How many patents has Dow filed in the last 10 years in which countries?
Portfolio analysis: How many inventions are held by BASF in different technological areas?
How many patents have been filed in the UK in the last 5 years dealing with fuel cells? What is the granting rate of the main patent applicants in the area of cosmetics in the most important markets? How many EP applications of Unilever, filed in 2004, are already dead? To what extend are granted EP patents opposed in the cosmetics industry?
7
Agenda • INPADOCDB / INPAFAMDB database structure • Commands and tools for statistical analysis • Analysis examples – – – – – – –
Company filing activity by year Company filing activity by year and country Patent portfolio Measuring the average patent lifespan Opposing companies Competitor citations Filing activity in a technical area by company
• Useful tools for compiling Company name queries
8
Statistical analysis on STN available commands and tools
SELECT • Extract terms and simple analysis
ANALYZE • Statistically analyze an answer set
TABULATE • Generate 2D table from ANALYZE answers
ANALYZE PLUS • Interactive ANALYZE
STN AnaVist • Patent mapping software
9
SELECT command • SELECT command – Statistically analyses the content of Display fields of an existing single file answer set – Extracts all unique terms within the analysed fields up to 999 terms and sorts terms acc. to their occurence – Creates a list of E-numbers (max. 999 E numbers) – E-numbers can be searched manually => S PYRROLIZIDINE/TI L1
69 PYRROLIZIDINE/TI ((PYRROLIZIDINE OR PYRROLIZIDINES)/TI)
=> SEL L1 IN E1 THROUGH E139 ASSIGNED
=> D SEL E1 E2 ...
13 13
MIYANO, SEIJI/IN SUMOTO, KUNIHIRO/IN 10
Analyze command • ANALYZE command – Statistically analyses the content of Display fields of an existing single or multi file answer set – Extracts all unique terms up to max. 50.000 within the analysed fields; size limit for analyzed answer set: 50.000 answers – Creates L# of terms – 1D table with => D ANA • Sort: occurrence, number of documents or alphabetically => FIL INPADOCDB A61K0008 => S A61K0008/IPC,CPC AND DE/PC L2 26703 A61K0008/IPC,CPC AND DE/PC Cosmetics or similar toilet
preparations
=> ANALYZE L2 AY PAS L5 ANALYZE L4 1- AY PAS :
1844 TERMS
11
Display Analyze answer set => D PAS DOC L5
ANALYZE L4 1- AY PAS :
D PAS DOC displays the patent assignee list sorted according to the number of records (documents) in descending order 1844 TERMS
TERM # # OCC # DOC % DOC AY PAS ------ ------- ------ ------ --------------2 825 825 10.69 OREAL 4 762 762 9.88 HENKEL AG & CO KGAA 5 732 732 9.49 BEIERSDORF AG 11 548 548 7.10 HENKEL KGAA 17 255 255 3.31 UNILEVER NV 19 220 220 2.85 PROCTER & GAMBLE 21 165 165 2.14 KAO CORP 23 127 127 1.65 COGNIS IP MAN GMBH 24 125 125 1.62 MERCK PATENT GMBH 25 121 121 1.57 WELLA AG
12
TABULATE command • TABULATE command – Requires at least a 2 field analysis by ANALYZE – Creates a 2-D table of an ANALYZE answer set, e.g. patent assignees by application year – 3 different formats available, e.g. one with term separators for later statistical analysis => FIL INPADOCDB => S A61K0008/IPC,CPC AND DE/PC L1
26740 A61K0008/IPC,CPC AND DE/PC
A61K0008 Cosmetics or similar toilet preparations
=> ANALYZE L1 AY PAS L2
ANALYZE L1 1- AY PAS :
1744 TERMS
13
Resulting table in GRID format => TABULATE L2 DISPLAY AS GRID FORMAT (N), Y, OR ?:Y ENTER PRIMARY DISPLAY CODE OR (?):PAS ENTER SECONDARY DISPLAY CODE OR (?):AY ... L3 ANALYZE L2 1- AY PAS : 1744 TERMS
AY ----------------------------------------------------------PAS 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 ... ------------------- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---BEIERSDORF AG 1 2 59 66 42 88 102 97 124 112 145 ... HENKEL AG & CO KGAA 0 7 114 138 177 156 114 15 14 16 8 HENKEL KGAA 0 0 6 0 0 0 16 186 167 115 51 OREAL 0 0 0 1 1 5 26 63 98 109 128 WELLA AG 0 0 0 0 0 0 0 0 39 73 30 UNILEVER NV 0 1 0 0 0 5 11 22 33 29 37 BASF AG 0 0 0 0 0 0 1 1 38 31 32 MERCK PATENT GMBH 0 0 7 16 4 5 12 22 22 24 13 PROCTER & GAMBLE 0 0 0 1 0 1 4 10 20 20 21 KAO CORP 0 0 0 0 0 3 0 4 14 17 30 ... 14
Agenda • INPADOCDB / INPAFAMDB database structure • Commands and tools for statistical analysis • Analysis examples – – – – – – –
Company filing activity by year Company filing activity by year and country Patent portfolio Measuring the average patent lifespan Opposing companies Competitor citations Filing activity in a technical area by company
• Useful tools for compiling Company name queries
15
Filing activity of a patent assignee by year Search Question: Which field can be used for a meaningful analysis of the last years – application date/year or priority date/year? Search in INPADOCDB with application and priority years.
16
Appl. Year vs. Priority Year – which one to choose? => FIL INPADOCDB => S (UNILEVER OR EMBALLAGES FRANCE OR FOLIE FORCHHEIM OR HINDUSTAN LEVER OR LEVER BROS)/PASS L2
68264 (UNILEVER OR EMBALLAGES …
Application Year /AY
PASS search for Unilever
First Priority Year /PRYF
=> S L2 AND AY=2000 L3 2914 L2 AND AY=2000
=> S L2 AND PRYF=2000 L8 2898 L2 AND PRYF=2000
=> S L2 AND AY=2005 L4 2140 L2 AND AY=2005
=> S L2 AND PRYF=2005 L9 1776 L2 AND PRYF=2005
=> S L2 AND AY=2008 L5 1453 L2 AND AY=2008
=> S L2 AND PRYF=2008 L10 1237 L2 AND PRYF=2008
=> S L2 AND AY=2009 L6 1213 L2 AND AY=2009
=> S L2 AND PRYF=2009 L11 816 L2 AND PRYF=2009
Pick AD/AY for analyzing recent => S L2 AND AY=2010 => Syears. L2 AND PRYF=2010 L12 627 L2 AND PRYF=2010 L7 857 L2 AND AY=2010 17
Granted patents per assignee, year and country Search Question: Search for Unilever patents which have been filed from 2001-2010 and have been granted subsequently. How many applications has Unilever filed in which countries over the last 10 years from 2010? Search in INPADOCDB
ANALYZE PLUS Application year and application country
EXCEL Check results in interactive table and 3D chart
Option Click interactive table to get specific STN resuts
18
Unilever applications per year and country => S L2 AND ((2001-2010)/AY (L) GRANTED/STA) L3
7866 L2 AND ((2000 …
Search for granted Unilever patents of the last 10 years, starting from 2010.
19
Interactive ANALYZE PLUS chart and table
An interactive table and a chart are created automatically EP, ZA, US, AT and DE are the main application countries.
20
Find patents that are still alive Search Question: Which Unilever US patents are still valid? Basic search in INPADOCDB
Calculated expiration dates help to exclude patents which died a natural death
Use legal status code categories To determine unnatural deaths
21
STN-assigned legal status categories simplify legal status searches (/LSC2) CHG EXA LIC NIF ORE REI SPC
Change of Owner, Inventor, Applicant Examination, Search Report Licensing Lapses, Expiries, Withdrawals, Refusals Opposition, Reexamination Reinstatement or Restoration Supplementary Protection Certificate
Summary information on INPADOCDB SPC coverage is provided at: http://www.epo.org/patents/patent-information/raw-data/inpadoc-faq.html#v 22
Use INPADOCDB to measure the patent lifecycle • INPADOC legal status events for important offices reveal all post grant events, thus tell you about “unnatural” patent deaths – INPADOC legal status is not legally binding, the register data has to be checked – For some countries, no grants are delivered, e.g. AR, so mind the database coverage – INPADOC legal status normally does not inform about a natural patent death but calculated expiration dates (XPD) help to identify patents that died “naturally”
23
Calculated expiration dates added to INPADOCDB » From filing year 1980 » For granted publications of 30 major patent authorities
» Almost 97 % of all grants covered since 1980
• More than 400 rules operate behind the scene • Calculation Principles – Patent laws and patent law changes since 1980 • Patents, utility models, design and plant patents and related publication types
– Earliest effective filing date is determined • crucial date to calculate the patent term depending on patent law Learn more in INPADOC News 2013/01
24
Alive Unilever US patents Basic search in INPADOCDB
Calculated expiration dates help to exclude naturally died patents
Use legal status code categories To determine unnatural deaths
=> S (UNILEVER OR … L1
68264 (UNILEVER OR …
Exclude patents that die after 15.05.2013.
=> S L1 AND US/PC AND XPD>20130515 L2
1452 L1 AND US/PC AND XPD>20130515
=> S L2 AND NIF/LSC2 NOT REI/LSC2 L3 381 L2 AND NIF/LSC2 NOT REI/LSC2 Exclude => S L2 NOT L3 L4 1071 L2 NOT L3
patents which are not in force anymore (/NIF) and have not been reinstated (/REI).
25
Alive Unilever patents per country => D BIB 1L4 ... TI TL IN INS PA PAS DT PI PIT DAV STA AI AIT ... XPD REC
ANSWER X OF 1071
INPADOCDB COPYRIGHT 2013 EPO/FIZ KA on STN
Electrochemical method and system for dyeing and highlighting hair. English BARTOLONE JOHN BRIAN; PREM PADMAJA; JACOBS-DUBE KATHERINE BARTOLONE JOHN BRIAN, US; PREM PADMAJA, US; JACOBS-DUBE KATHERINE, US UNILEVER HOME & PERSONAL CARE USA, DIVISION OF CONOPCO, INC. UNILEVER HOME & PERSONAL CARE, US Patent US 6994733 B2 20060207 English USB2 REEXAM. CERTIF., N-ND REEXAM. or GRANTED PATENT AS SECOND PUBLICATION [FROM 2001 ONWARDS] 20060207 printed-with-grant GRANTED US 2004-937553 A 20040909 USA Patent application
The life of this US patent ends in 2023.
20231113 7. THERE ARE 7 CITED REFERENCES (7 PATENT, 0 NON PATENT) AVAILABLE FOR THIS RECORD. ALL CITATIONS ARE AVAILABLE IN THE RE FORMAT. PNC.G 1. THERE IS 1 CITING PATENT REFERENCE AVAILABLE FOR THIS RECORD. ALL CITING REFERENCES ARE AVAILABLE IN THE CGP FORMAT. 26
Average timeframe of patent protection Search Question: What is the average timeframe patent protection for German patents is maintained by Unilever? Strategy has to be country specific. Find out post-grant not in force legal status codes Expiry date not present for every country
Basic search in INPADOCDB
Restrict to granted patents from one patent country
Use legal status code categories to determine the patent liefespan
Analyze application year and hit legal status date
Process in e.g. Excel
27
Unilever patent protection time for Germany => S (UNILEVER OR EMBALLAGES ...LEVER BROS)/PASS AND (DE)/PC (L) GRANTED/STA (L) (1990-2013)/AY L1 2441 (UNILEVER OR ... Legal status category Not in force (NIF) => S L1 AND NIF/LSC2(L)(1990-2013)/LSD L2 1040 L1 AND NIF/LSC2(L)(1990-2013)/LSD => ANA L2 1- LSD AY HIT L3 ANALYZE L2 1- LSD AY HIT :
Analyze LSD and AY hits only. 330 TERMS
=> TABULATE DELIM L3 AY ALP D LSD ALP D L3 ANALYZE L2 1- LSD AY HIT :
Tabulate AY and LSD to create a 2-D table for post 330 TERMS processing
1;0.10;2008;20101118 2;0.19;2007;20110519 1;0.10;2006;20110616 1;0.10;2006;20110519 ...
1
Number of docs
0.19
Share of docs
2006
Application year
20110519 Legal status date 28
NIF events for DE grants by AY Documents (sum by AY and yearly numbers for LSD) AY = 1990 90 1995 6 1996 10 1997 9 1998 5 1999 5 2000 5 2001 5 2002 7 2003 8 2004 8 2005 1 2006 4 2007 5 2008 6 2009 1 2010 5 AY = 1991 69 1996 4 1997 7 … … * derived from Legal Status Date (LSD) NIF event year* by application year
On average Unilever holds patent protection in Germany for documents from: AY 1990 for 13.3 years AY 1991 for 11.59 years …
29
DE lapses - example HIT displays => D L2 HIT 1 100 L2 PA PAS STA PI AI
ANSWER 1 OF 1040 INPADOCDB COPYRIGHT 2013 EPO/FIZ KA on STN UNILEVER N.V. Patent protection for a UNILEVER NV, NL GRANTED application from 2007 DE 602007007784 D1 20100826 expired in May 2011. DE 2007-602007007784 A 20070731
DE
LEGAL STATUS HIT AN 61746487 INPADOCDB 20110519DE8339 - CEASED/NON-PAYMENT OF THE ANNUAL FEE NIF Lapses, Expiries, Withdrawals, Refusals .......................................20110519 L2 PA PAS STA PI AI
ANSWER 100 OF 1040 INPADOCDB COPYRIGHT 2013 EPO/FIZ KA on STN UNILEVER N.V.; UNILEVER PLC Patent protection for a DE UNILEVER NV, NL; UNILEVER PLC, GB GRANTED application from 2001 DE 60123263 D1 20061102 expired in August 2007. DE 2001-60123263 A 20011017
LEGAL STATUS HIT AN 50713895 INPADOCDB 20070823DE8339 - CEASED/NON-PAYMENT OF THE ANNUAL FEE NIF Lapses, Expiries, Withdrawals, Refusals .......................................20070823
30
Opposition analysis Search Question: Who opposes the patents of the molecular diagnostics company Qiagen? Make use of the legal status information in the INPADOCDB database.
31
Identify legal competitors of QIAGEN => FIL INPADOCDB Company search for Qiagen in the => S QIAGEN/PASS 1618 QIAGEN/PA assignee super search field (/PASS). 1616 QIAGEN/PAS 643 QIAGEN/LSPA L1 1904 QIAGEN/PASS (QIAGEN/PA,PAS,LSPA) => S L1 AND ORE/LSC2 208619 ORE/LSC2 L2 30 L1 AND ORE/LSC2
Narrow the search to only include hits for oppositions…
=> ANA LSOP L3 ANALYZE L2 1- LSOP :
…and analyze the legal opponents in 17 resulting TERMS the records.
=> D 1- DOC L3 ANALYZE L2 1- LSOP : TERM # # OCC # DOC % DOC ------ ------- ------ -----1 10 3 10.00 2 5 3 10.00 3 5 2 6.67 4 5 1 3.33 ... ********* END OF L3 ***
17 TERMS
LSOP --------------MACHEREY, NAGEL GMBH & CO.KG ROCHE DIAGNOSTICS GMBH COBRA THERAPEUTICS LIMITED In this simple example PROMEGA CORPORATION
Machery Nagel and Roche are the main legal opponents of Qiagen.
32
Study competitors by analyzing patent citations Search Question: The company QIAGEN is interested if any competitors have published inventions very close to their technology. Use specific features of the INPAFAMDB database to find competitors with strongly related technologies.
33
References (citations) in Patent documents • Reference to a previous work (prior art) that is considered relevant to current patent application (patent or non-patent) • Location of citations: front (e.g. US) or back (e.g. EP) • Premise for patent citation searching: – patent document cites an earlier publication – patent document is cited by a subsequent publication – This patent document and the earlier and/or subsequent publications are related by subject matter
• Sources of citation: applicant, examiner, opposition, third party 34
INPADOC cited and citing patent information Master (2) references cited citing
Older document 1
1
3
(citing 2)
(cited by 2)
• • •
•
Cited references from 26 patent authorities > 85 million citations in 9.3 million patent families from 1943 onwards Search in /RPN (Referenced Patent Number) or /REN (Referenced NonPatent Literature) Standard Display for citation information: RE (PIRE for INPAFAMDB) EPO DOCDB raw data source for citation coverage.
More recent document 3
• •
• • •
Citing references Available for > 19 million applications Citing patent number, publication date, citing patent assignee, and cited patent number included in standard display formats, e.g. MAX and IFAM Custom display with CGP available Display backward and forward citations with CITN Learn more in INPADOC News 2013/01 35
Concept: Competitor analysis many citings time
1
2 3 4 5
Numbers are only variables!
patent (1)
references cited …
More recent patent More recent 2patent More recent (citing 1)
3patent More recent (citing 1) 4patent (citing 1) 5 (citing 1)
Patent 1
Citing patent 1 Task: a) Find patents/inventions that cite patent 1 b) Extract the assignee names and sort them according to number of citings (of patent 1) 36
Identify potential competitors of QIAGEN => FIL INPAFAMDB => S QIAGEN/PASS
L1
396 395 361 467
=> TRANSFER L1 PN 1- /RPN L2 L3 L4
TRANSFER publication numbers (PN) number
TRANSFER L1 1- PN : 3194 TERMS to the referenced publication 2733 L2/RPN QUE TERMS FROM L2/RPN field WITH/RPN. NO HITS: 2311 TERMS
=> S L3 NOT QIAGEN/PA,PAS L5
Company search for Qiagen in the super search field (/PASS).
QIAGEN/PA assignee QIAGEN/PAS QIAGEN/LSPA QIAGEN/PASS (QIAGEN/PA,PAS,LSPA)
396 QIAGEN/PA 395 QIAGEN/PAS 2536 L3 NOT QIAGEN/PA,PAS
Exclude self-citations.
=> S L3(S)(X OR I)/CAT NOT QIAGEN/PA,PAS L7 443 L3(S)(X OR I)/CAT NOT QIAGEN/PA,PAS
Option: Use (S) proximity to refine the QIAGEN cited patent numbers (/RPN) with an “X or I” search report category (/CAT). Again, exclude self-citations. 37
Identify potential competitors of QIAGEN => D BRIEF PIRE L5 19
A recommendable display format is BRIEF PIRE: a) Short overview content KA andonbibliography + INPAFAMDB COPYRIGHT 2013ofEPO/FIZ STN b) Cited references
L5
ANSWER 19 OF 2536
AN TI
48330688 INPAFAMDB EDF 20130214 EWF 201307 UPFB 20130328 UWF 201313 Method for isolating RNA from full blood samples. METHOD FOR ISOLATING RNA FROM WHOLE BLOOD SAMPLES. KIRSCH CHRISTOPH DR, DE; BEYARD CLAUDIA, DE; MEUSEL MARKUS DR, DE; ZINN THOMAS DR, DE; WAGNER CAROLIN, DE; MOELLER KLAUS DR, DE; BAYARD CLAUDIA, DE; KIRSCH CHRISTOPH, DE; MEUSEL MARKUS, DE; ZINN THOMAS, DE; MOELLER KLAUS, DE AXAGARIUS GMBH & CO KG, DE KIRSCH CHRISTOPH, DE BEYARD CLAUDIA, DE MEUSEL MARKUS, DE
INS
PAS ... IPCI CPC INCL AB
C12N0015-10 [I,A]; C07H0001-08 [I,A]; C12N0009-50 [I,A] C12N0015-1006; C12N0001-06; C12N0015-1003 INCLM 536/025.410 INCLS 435/219.000 (EP 2557161 A1) Isolating RNA from a whole blood sample comprises (a) contacting the sample with an aqueous lysis solution containing 1.5-7 mole/l of at least ... 38
Identify potential competitors of QIAGEN => D BRIEF PIRE PATENT FAMILY INFORMATION INPAFAMDB +-------- Publications --------+ DE 102011080853 A1 20130214 EP 2557161 A1 20130213 US 20130041145 A1 20130214
+-------- Applications --------+ DE 2011-102011080853 A 20110811 EP 2012-171498 A 20120611 US 2012-13572072 A 20120810
+--------- Priorities ---------+ DE 2011-102011080853 A 20110811 1 priority, 3 applications, 3 publications
Patent family information a) EPO Publications (1 simple family) b) Applications c) Priorities
39
Identify potential competitors of QIAGEN
Member 1
PI REP
REN
REC
Member 2
PI REP
REXP
REN
REC ...
DE 102011080853 A1 20130214 PI reveals the citing US 5010183 A 19910423 (SEA, pat) MACFARLANE DONALD E, US publication (DE application). EP 875271 A2 19981104 (APP, pat) QIAGEN GMBH, DE The DE patent cites ... (1) Boeyum, 1968; Isolation of mononuclear cells and publication. granulocytes from a US human blood. Scand. J. Clin. Lab. Invest. 21 (Suppl. 97): 77-89 (APP) (2) Karavitaki et al., 2005, Molecular staging using qualitative RT-PCR analysis detecting thyreoglubulin mRNA in the periphereal Blood of ... (4) Ed. F. M. Ausubel. 1999 Wiley (APP) 15. THERE ARE 15 CITED REFERENCES (11 PATENT, 4 NON PATENT) AVAILABLE FOR THIS RECORD. EP 2557161 A1 20130213 Patents and non patent US 5010183 A 19910423 (SEA, pat, Cat: XD) documents are cited. MACFARLANE DONALD E, US WO 2000009746 A1 20000224 (SEA, pat, Cat: YD) ... XP055042655 (SEA, Cat: Y) The EP application cites 23 XP055042803 (SEA, Cat: A) publications. ... (1) "Isolation of Total RNA from Whole Blood and from Cells Isolated from Whole Blood Protocol", , 1. August 2004 (2004-08-01), XP55042655, ... 23. THERE ARE 23 CITED REFERENCES (14 PATENT, 9 NON PATENT) AVAILABLE FOR THIS RECORD.
40
Identify potential competitors of QIAGEN => ANALYZE L5 1- PAS L6
ANALYZE L5 1- PAS :
8410 TERMS
=> D DOC 1-15 L6
ANALYZE L5 1- PAS :
8410 TERMS
INPAFAMDB Analyzing the patent assignee standardized (PAS) of patents referencing QIAGEN patent publications…
TERM # # OCC # DOC % DOC PAS ------ ------- ------ ------ --------------1 72 72 2.84 ROCHE DIAGNOSTICS GMBH 2 63 63 2.48 HOFFMANN LA ROCHE 3 61 61 2.41 LIFE TECHNOLOGIES CORP …reveals that Roche is the 4 57 57 2.25 APPLERA CORP 5 39 39 1.54 NOVARTIS AG main competitor whose 6 38 38 1.50 APPLIED BIOSYSTEMS LLC patents cite QIAGEN 7 37 37 1.46 BECTON DICKINSON CO documents. 8 34 34 1.34 AGILENT TECHNOLOGIES INC 9 30 30 1.18 3M INNOVATIVE PROPERTIES CO 10 28 28 1.10 ROCHE MOLECULAR SYSTEMS INC We displayed the ANALYZE 11 28 28 1.10 US HEALTH 12 25 25 0.99 HITACHI LTD list according to the number of 13 23 23 0.91 ILLUMINA INC documents (DOC), not 14 23 23 0.91 INVITROGEN CORP (OCC)! 15 22 22 0.87 NOVARTIS VACCINES occurences & DIAGNOSTIC 41
Filing behavior of companies in a technical field - ANALYZE PLUS Search Question: Identify the main companies innovating in the field of active safety systems in vehicles. Search in INPAFMADB and use ANALYZE PLUS to automatically create an interactive results table and a chart.
42
Start ANALYZE PLUS from the wizard B60R0021-01/IPC Electrical circuits for triggering PRYF>=2006 safety arrangements in case of vehicle accidents
=> FIL INPAFAMDB => S B60R0021-01+NT/IPC AND PRYF>=2006 L1
3280 B60R0021-01+NT/IPC AND
Which patent assignees (PAS) applied for patent protection in which years (PRYF)?
43
Interactive ANALYZE PLUS chart and table
An interactive table and a chart are created automatically Bosch, Denso/Toyota and Hyundai are the main innovaters 44
Agenda • INPADOCDB / INPAFAMDB database structure • Commands and tools for statistical analysis • Analysis examples – – – – – – –
Company filing activity by year Company filing activity by year and country Patent portfolio Measuring the average patent lifespan Opposing companies Competitor citations Filing activity in a technical area by company
• Useful tools for compiling Company name queries
45
DWPI Patent Assignee Codes (/PACO) • More than 21,000 standardized assignee codes • Patent Assignee Codes printed Manual – http://www.thomsonscientific.com/media/scpdf/patenteecodes.pdf
• Web Version – http://scientific.thomsonreuters.com/support/patents/dwpiref/reftool s/companycodes/lookup/
• STN online thesaurus • Searching: – E.g. E MERI-C/PACO Note: Standard patent assignee codes extended to cover
all assignees with 500 or more patent records. 46
CAplus Company Thesaurus (/CO) • Search aid to identify related forms of company names in the /CO field • Focus is on most frequently occurring PA names and names of major chemical companies (patents + non-patent literature) • Each company name family is assigned a company number for identification (CNUM) • over 40.000 company name families included Example: Identify CIBA Geigy and search for its patents 1) => E CIBA SPEC/CO 2) => E CIBA SPECIALTY CHEMICALS CORP+ALL/CO 3) => S CIBA SPECIALTY CHEMICALS CORP+ALL/CO AND P/DT 47
For more information … CAS E-mail:
[email protected] Support and Training: www.cas.org
FIZ Karlsruhe
[email protected] Support and Training: www.stn-international.de